XPENG Announces Vehicle Delivery Results for March and First Quarter 2023
The new sports sedan P7i, launched in March for the Chinese market, has generated favorable market reception and its order backlog is gathering strong momentum. A total of 3,030 P7 series sedans were delivered in March, representing a 32% increase month-over-month.
The launch of the new P7i also boosted the Company’s store traffic, pushing test drive volume to recent heights. Delivery of the P7i began nationwide in March.
Safe Harbor Statement
This announcement contains forward-looking statements. These statements are made under the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as “will,” “expects,” “anticipates,” “future,” “intends,” “plans,” “believes,” “estimates” and similar statements. Statements that are not historical facts, including statements about XPENG’s beliefs and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties. A number of factors could cause actual results to differ materially from those contained in any forward-looking statement, including but not limited to the following: XPENG’s goals and strategies; XPENG’s expansion plans; XPENG’s future business development, financial condition and results of operations; the trends in, and size of, China’s EV market; XPENG’s expectations regarding demand for, and market acceptance of, its products and services; XPENG’s expectations regarding its relationships with customers, contract manufacturers, suppliers, third-party service providers, strategic partners and other stakeholders; general economic and business conditions; and assumptions underlying or related to any of the foregoing. Further information regarding these and other risks is included in XPENG’s filings with the
View source version on businesswire.com: https://www.businesswire.com/news/home/20230401005036/en/
For Investor Enquiries:
Tel: +1 212 481 2050 / +86 10 6508 0677
For Media Enquiries: